| Screening people with type 2 diabetes at risk for foot ulceration in Iran. | |
| | |
MedLine Citation:
|
PMID: 20707739 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Foot screening is one of the most effective means of preventing foot complications in diabetes. Therefore the aim of this study was to perform a screening program for people with type 2 diabetes at risk of foot complications. METHODS: Physical examinations consisting of vascular, neurological, musculoskeletal, and dermatologic examinations were performed. We used a Semmes-Weinstein monofilament and a 128-Hz tuning fork to test peripheral neuropathy. The study population was categorized based on Scottish Intercollegiate Guidelines into three groups of low, medium, and high risk for diabetes foot disease. RESULTS: Of a total of 148 people with type 2 diabetes, 4.7% had an active foot ulcer, and 41.9% were classed as low risk, 40.6% as medium risk, and 12.8% as high risk. CONCLUSIONS: Considering the potential of developing risk of foot disease in people with diabetes, it is recommended that foot screening should be performed by primary care practitioners and specialists to detect foot disease in an early stage. Foot screening program for people with diabetes should also be taken into account by health policy makers in national guidelines. |
| | |
Authors:
|
Nasibeh Vatankhah; Younes Jahangiri Noudeh; Mohammad E Khamseh; Hamid R Baradaran |
Related Documents
:
|
8799709 - Foot lesions in patients with diabetes mellitus. 11305779 - Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in... 8829489 - Ultrastructural study of the dermal microvasculature in patients undergoing retrograde ... 2210969 - Diabetic ulcer healing preparations from the skin of the arabian gulf catfish (arius bi... 1248659 - Homologous artificial insemination and oligospermia. 11175259 - Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but ... 104699 - Histopathology in giardiasis: a correlation with diarrhoea. 17098259 - Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced... 20879969 - Alogliptin: a novel molecule for improving glycemic control in type ii diabetes mellitus. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Diabetes technology & therapeutics Volume: 12 ISSN: 1557-8593 ISO Abbreviation: Diabetes Technol. Ther. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-16 Completed Date: 2010-12-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100889084 Medline TA: Diabetes Technol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 731-6 Citation Subset: IM |
Affiliation:
|
Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran. nasibeh.vatankhah@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chi-Square Distribution Diabetes Mellitus, Type 2 / complications*, pathology Diabetic Foot / diagnosis, pathology*, prevention & control Female Humans Iran Male Middle Aged Risk Assessment / methods |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus.
Next Document: Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive bre...